Today: 23 January 2026
Subscribe
Browse Category

NYSE:PEN News 13 January 2026 - 16 January 2026

Boston Scientific (BSX) stock drops after $14.5B Penumbra deal; FDA nod and earnings date ahead

Boston Scientific (BSX) stock drops after $14.5B Penumbra deal; FDA nod and earnings date ahead

New York, Jan 15, 2026, 18:09 (ET) — After-hours update. Shares of Boston Scientific Corp (NYSE: BSX) dropped roughly 4% Thursday following its deal to acquire blood-clot treatment company Penumbra. Boston Scientific’s stock slipped $3.75, closing near $90.03 in late U.S. trading. Meanwhile, Penumbra (NYSE: PEN) surged around 12%, reaching $350.49. Boston Scientific announced it will pay $374 per Penumbra…
16 January 2026
·····
Penumbra (PEN) stock slides 5% after CEO flags manufacturing shift at JPM conference

Penumbra (PEN) stock slides 5% after CEO flags manufacturing shift at JPM conference

New York, Jan 13, 2026, 15:57 EST — Regular session Penumbra (NYSE: PEN) shares dropped Tuesday following comments from CEO Adam Elsesser about shifting the company’s manufacturing base. The stock slid 5.2% to $302.70 in late trading after hitting a low of $290.42 earlier. Elsesser told a conference that “All of our products today are manufactured in California. That’s going…
13 January 2026
····

Stock Market Today

  • West Pharmaceutical Services Falls to Oversold Levels with RSI at 27.1
    January 23, 2026, 1:52 PM EST. West Pharmaceutical Services (WST) shares fell into oversold territory on Friday, with the Relative Strength Index (RSI) dropping to 27.1, below the 30 threshold that signals potential buying opportunities. The stock traded as low as $232.06, against a 52-week range of $187.43 to $348.90. In comparison, the S&P 500 ETF (SPY) held an RSI of 53.2. Oversold conditions suggest recent selling pressure may be easing. Investors monitoring momentum indicators like the RSI, which measures price movement strength on a 0-100 scale, might consider WST for entry points. This move aligns with investor Warren Buffett's advice to be cautious when markets are eager and opportunistic when they show fear.
Go toTop